➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Iniparib

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Iniparib?

Iniparib is an investigational drug.

There have been 20 clinical trials for Iniparib. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2009.

The most common disease conditions in clinical trials are Breast Neoplasms, Triple Negative Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Sanofi, SOLTI Breast Cancer Research Group, and UNC Lineberger Comprehensive Cancer Center.

Recent Clinical Trials for Iniparib
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical TrialSanofiPhase 3
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid TumorsSanofiPhase 1
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer PatientsSOLTI Breast Cancer Research GroupPhase 2

See all Iniparib clinical trials

Clinical Trial Summary for Iniparib

Top disease conditions for Iniparib
Top clinical trial sponsors for Iniparib

See all Iniparib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.